🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The Sanger Prize Competition 2025 - calling for undergraduate students in LMICs The winner will be offered a 3month internship with travel, living and research expenses are all covered by the award. sanger.ac.uk/about/the-sang… #sangerinstitute

This World AMR Awareness Week, meet Caroline Tigoi, a PhD candidate at Oxford and scientist at KEMRI-Wellcome Trust. As the global threat of antimicrobial resistance grows, Caroline is focused on stopping it in its tracks – and her research is promising. Hear her story: #WAAW

Two E.coli strains could be linked with higher rates of certain cancers in countries such as the UK. Targeting them with treatments or vaccines could help reduce the risk of colorectal, bladder, and prostate cancers 💊 sanger.ac.uk/news_item/poss…

New personal view article Geographical variation in the incidence of colorectal cancer and urinary tract cancer is associated with population exposure to colibactin-producing Escherichia coli thelancet.com/journals/lanmi… #OpenAccess #OA

Faculty opportunity Wellcome Sanger Institute in the Parasites & Microbes programme! Seeking microbiologists & data scientists passionate about high-throughput omics to tackle big questions. Apply now: sanger.wd103.myworkdayjobs.com/en-US/Wellcome…

Introducing our latest preprint which discovered Clostridium sp. grow on HMOs. Using computational and experimental approaches we show this has beneficial consequences for the developing microbiome and the host. But there is nuance. A 🧵... biorxiv.org/content/10.110…

Conducting research in LMICs is undeniably challenging, with brain drain often surpassing reverse brain drain. Grateful to Nature Reviews Microbiology for the opportunity to share an opinion discussing both the difficulties and rewards of working in this space. rdcu.be/d7O5Q [1/2]

Delighted to see our latest paper out in Nature Microbiology. We show that different types of LPS from the gut microbiota modulate efficacy of immunotherapy in melanoma. A potential new biomarker and enhancer for treatment response. Exciting for the field! nature.com/articles/s4156…

Heading to #Microbio25? See how HiFi sequencing on #Vega & #Revio enables microbial genomics at scale. 📍 Don’t miss our talk! 🎤 Yan Shao (Wellcome Sanger Institute) 📅 Wed, April 2 | 13:15 - 13:45 Can’t attend? Check out our Microbiology brochure ⬇️ 🔗 bit.ly/4brjiYq📅

If you have experience in sc/spatial transcriptomics with an interest in microbes....come and join our team as a computational postdoc: sanger.wd103.myworkdayjobs.com/WellcomeSang... Incredibly exciting datasets on host-microbe interactions in the lung. Pls RT and reach out if you are interested

🚨 We’re #hiring a Staff Scientist to drive innovative computational workflows for large-scale, multi-omics data in human microbiome research Dr Trevor Lawley Wellcome Sanger Institute 📅 Closing date: 27th April 2025 📢 Please share & apply! sanger.wd103.myworkdayjobs.com/en-US/Wellcome…

Looking forward to speaking at the Microbiology Society conference next week! I’ll be sharing how we’re applying HiFi long-read sequencing with the latest multiplexing kit to replace the hybrid approach for generating complete reference genomes of gut microbial isolates. #Microbio25

It was a pleasure to write about exciting advances in strain-level metagenomics alongside our brilliant students, Bonface Gichuki and Andrew Van Camp. We believe this represents a critical step toward enabling precision microbiome therapeutics.

Targeted pathobiont inhibition mitigates alcohol-associated liver disease: E. coli KpsM associates w/increased mortality in patients w/alcohol-associated hepatitis. In mice, KpsM allows evasion of phagocytosis w/KpsM inhibitor ameliorating disease cell.com/cell-host-micr…